Neko Health, co-founded by Spotify CEO Daniel Ek, has secured $700 million in Series C funding to expand its body-scanning clinics to New York. The startup, which combines hardware scanning with blood tests, has seen over 100,000 users to date. This capital will support the company's entry into the competitive US preventive healthcare market following its initial growth in Europe.
Neko Health, the preventive health technology company co-founded by Daniel Ek of Spotify and Hjalmar Nilsonne, has finalized a $700 million Series C funding round. The investment was led by Lightspeed Venture Partners and O.G. Venture Partners, with participation from existing backers such as Atomico and General Catalyst. This round follows a $260 million Series B raise in early 2025, signaling rapid capital deployment for the company's international growth strategy.
Technology and Service Model
The company operates specialized clinics that utilize proprietary scanning hardware designed to perform comprehensive physical assessments. These scans are combined with blood analysis and body composition metrics to provide a data-driven health profile. By integrating with existing platforms like Apple Health, the company aims to provide clinicians with longitudinal data. This approach represents a shift toward technology-enabled preventive care, though the model faces the inherent challenge of integrating with traditional medical systems and ensuring regulatory compliance across different healthcare jurisdictions, including the United States.
Scaling Operations and Market Reach
With operations currently established in Sweden and the UK, the company is preparing for its first US location in New York City. The startup reports a user base of over 100,000 individuals who have completed scans, alongside a waitlist exceeding 350,000 people. This indicates a strong consumer interest in proactive health monitoring. However, as the company enters the US market, it must navigate complex health insurance reimbursement landscapes and competing preventive health services, which are often not fully covered by standard medical insurance.
Competitive Environment
The preventive scanning and health-tech sector is becoming increasingly crowded. Other technology firms and entrepreneurs are entering the space with similar wellness-focused diagnostics. For instance, MidJourney is reportedly working on a body-scanning experience for the wellness industry, targeting a 2027 opening in San Francisco. For investors and observers, the key monitorable will be how Neko Health maintains its value proposition as these specialized services become more common. Success will likely depend on the company's ability to demonstrate clinical utility and maintain consumer demand as it expands beyond its early adopter base in Europe to a broader US audience.